De Novo Submission Software
Coordinate evidence planning, risk controls, and classification rationale for De Novo filings. Reduce late rewrites and build a more defensible novel-device submission.
De Novo Filing Workflow
See where De Novo programs lose time across drafting, review, validation, and readiness.
Go From 3 Weeks of Review Cycles to 48 Hours
Keep device description, intended use, risk controls, and evidence strategy aligned in one workflow
Stop Losing Documents Between 5 Different Systems
Track test results, clinical inputs, and classification rationale with full decision traceability
Know Your Exact Readiness Score at Any Moment
Coordinate RA, QA, engineering, and clinical workstreams against one submission plan
Never Miss a Submission Deadline Again
Reduce late-cycle rewrites by surfacing unsupported claims and missing evidence earlier
De Novo Filing Controls and Capacity
Keep submission growth controlled with clearer ownership, better traceability, and consistent execution across active programs.
Maintain Audit-Ready De Novo Records
FD&C Act Section 513(f)(2), 21 CFR Part 860, 21 CFR Part 820 aligned workflows with audit trails, role-based access, and submission traceability.
Manage More De Novo Programs With the Same Team Size
Prepare stronger review-question responses with linked source material and prior decisions
Questions About De Novo Submission Software
Practical questions buyers ask when evaluating de novo submission software.
